Literature DB >> 2934760

Osteoporosis in chronic cholestatic liver disease.

A J Stellon, A Davies, J Compston, R Williams.   

Abstract

Assessment for both trabecular and cortical osteoporosis was carried out in 36 unselected patients with chronic cholestatic liver disease of whom a number had received corticosteroids during the course of their illness. Symptoms suggestive of osteoporosis were present in 42 per cent of patients of whom 11 per cent had evidence of one or more wedged or collapsed vertebrae. There was a highly significant decrease in the cortical area (total area ratio of the second metacarpal (p = 0.05), bone mineral content at the metaphyseal site of the radius (p = 0.01) and the total trabecular bone volume of the iliac crest biopsies (p = 0.005) in the 31 female patients when compared with age and sex-matched healthy controls). There was a nonsignificant decrease in total trabecular bone volume of the iliac crest and bone mineral content of the radial metaphysis in the males compared with age and sex-matched controls but the cortical plate thickness of the iliac crest (p = 0.005) and bone mineral content of the radial diaphysis (p = 0.02) were significantly higher. In total, 42 per cent of patients had evidence of either excessive cortical (28 per cent) and/or trabecular (36 per cent) bone loss as judged by radiological and histological criteria. Only the total trabecular bone volume of the iliac crest, of all the parameters measured was significantly (p = 0.02) lower in patients with backache compared with those without back pain. Significantly greater bone loss was demonstrated at all sites measured in those patients that were receiving or had received corticosteroids in the past.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934760

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  11 in total

1.  Guidelines on the management of osteoporosis associated with chronic liver disease.

Authors:  Jane D Collier; M Ninkovic; J E Compston
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

Review 2.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

3.  Bone disorders in experimentally induced liver disease in growing rats.

Authors:  Viktória Ferencz; Csaba Horváth; Béla Kári; János Gaál; Szilvia Mészáros; Zsuzsanna Wolf; Dalma Hegedus; Andrea Horváth; Anikó Folhoffer; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 4.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

5.  Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.

Authors:  A J Stellon; A Webb; J E Compston
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

Review 6.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

7.  Osteoporosis in primary biliary cirrhosis revisited.

Authors:  J Newton; R Francis; M Prince; O James; M Bassendine; D Rawlings; D Jones
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

Review 8.  Hepatic disorders. Features and appropriate management.

Authors:  M A Aldersley; J G O'Grady
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

9.  Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.

Authors:  C H Janes; E R Dickson; R Okazaki; S Bonde; A F McDonagh; B L Riggs
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 10.  Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications.

Authors:  Inaam A Nakchbandi
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.